Global Reach Partnerships Skin Tech Pharma Group operates in more than 70 countries, presenting strong opportunities for distribution partnerships, private label programs, and contract manufacturing with clinics and pharmaceutical partners across its markets.

Flagship Injectable Advantage Its award winning RRS HA Long Lasting injectable is positioned as a premium offering for physicians and aesthetics clinics, with cross sell potential to the Peel2Glow line and Ultra M Cream for bundled patient care.

R&D and Partnerships With internal R&D and more than 30 years in aesthetic medicine, the group can pursue joint development of new formulations and delivery systems, including exploring graphene based materials through its OCSiAl partnership for potential enhancements of dermal implants and cosmeceuticals.

Regulatory Europe Advantage European regulatory readiness and CE marking for Class III devices enable contract manufacturing and compliant supply of injectables and devices to European clinics and pharma partners.

Marketing and Thought Leadership Active AMWC participation and the Experts Talk webinar series demonstrate brand authority and clinician engagement, creating channels for lead generation, education partnerships, and strategic sponsorship opportunities.